Primary myelofibrosis

Similar documents
Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Heme 9 Myeloid neoplasms

Hematology Unit Lab 2 Review Material

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

Juvenile Myelomonocytic Leukemia (JMML)

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

Morfologia normale e patologica

HEMATOLOGIC MALIGNANCIES BIOLOGY

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

بسم هللا الرحمن الرحيم

MYELODYSPLASTIC SYNDROMES

MYELOPROLIFERATIVE DISEASE. Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG

2 nd step do Bone Marrow Study If possible both the aspiration and

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic Syndromes Myeloproliferative Disorders

Case Presentation No. 075

Chronic Idiopathic Myelofibrosis (CIMF)

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Notes for the 2 nd histology lab

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Hematopathology Lab. Third year medical students

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

RAEB-2 2 Transforming to Acute Erythroleukemia Case # 165

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Myelodysplastic scoring system with flow cytometry. G Detry B Husson

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

Faculty of Medicine Dr. Tariq Aladily

Polycthemia Vera (Rubra)

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

Acute Myeloid Leukemia with Recurrent Cytogenetic Abnormalities

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination

CHALLENGING CASES PRESENTATION

Myelodyplastic Syndromes Paul J. Shami, M.D.

Table 1: biological tests in SMD

WHO Classification 7/2/2009

Laboratory Diagnosis for WBC Pathology

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016

Hematopathology Case Study

Chronic Myelomonocytic Leukemia with molecular abnormalities SH

MDS: Who gets it and how is it diagnosed?

About Myelodysplastic Syndromes

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Myelodysplastic Syndromes: WHO 2008

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS

Myelodysplastic Syndromes: Hematopathology. Analysis of SHIP1 as a potential biomarker of Disease Progression

Myelodysplastic syndromes

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

SH A CASE OF PERSISTANT NEUTROPHILIA: BCR-ABL

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T.

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION

MS.4/ 1.Nov/2015. Acute Leukemia: AML. Abdallah Abbadi

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Acute myeloid leukemia. M. Kaźmierczak 2016

5/21/2018. Disclosures. Objectives. Normal blood cells production. Bone marrow failure syndromes. Story of DNA

Formation of Blood Cells

MYELODYSPLASTIC AND MYELOPROLIFERATIVE

Leukaemia Section Review

Hematocrit. Hematocrit = using a centrifuge to separate out the parts of blood. Plasma Formed elements:

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Myelodysplastic Syndrome: Let s build a definition

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

WHO Classification of Myeloid Neoplasms with Defined Molecular Abnormalities

Blood Cell Identification: 2011-B Mailing: Acute Myeloid Leukemia (AML)

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

Blood Cell Identification Graded

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

Actual biological diagnosis of acute myeloblastic leukemia in children

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Blood Cell Identification Graded

Changes to the 2016 WHO Classification for the Diagnosis of MDS

Concise Review for Primary-Care Physicians

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

The diagnosis of myelodysplastic syndrome

Hemopoiesis and Blood

Proper Slide Preparation

Transcription:

- It s a bone marrow fibrosis Primary myelofibrosis - It's type of myeloproliferative disease i.e. neoplastic proliferation of mature cell of myloid linage. - Its similar to chronic myloid leukemia (CML). Recall the similarity between them that both are neoplastic proliferation of mature cell but CML occur because of translocation mutation which lead to form philadilphia chromosome - Increased megakaryopoesis lead to produce high amount of megakaryocyte which release platelet derived growth factor (PDGF) - PDGF activates fibroblast which synthesizes collagen causing marrow fibrosis. - At the beginning bone marrow is hypercellular due to granulopoesis and megakarypoiesis with the result that increasing WBC and platelet number. - Then bone marrow becomes hypocellular due to fibrosis. - Note that PB at slide 31 stands for peripheral blood. - At slide 33 as you see the bone marrow is hypocelluar (at middle of image low of cells)and spindle shaped stroma because of fibrosis. - At upper right you can notice megakaryocyte which is atypical and large in number while at CML is typical in shape Myelodisplastic syndrome(mds) - Different mutations (high number of mutation) prevent stem cell to continue maturation lead to dysplasia (abnormal shape) and cytopenia(decrease cell count). - It's common cause of anemia with decrease bone marrow production like megaloblastic anemia.

- Different mutations, but mutations here are more aggresive than myloprolifrative disease. - Myeloprolifrative disease : mutation occur at gene level (like JAC2 or ABL) but, myelodisplastic syndrome : mutations occur at level of chromosome(all chromosome) and usually deletion mutations so more aggressive mutation and more defective (abnormal) cells. - Because cell are morphologically abnormal so can't leave the bone marrow to peripheral blood causing peripheral blood cytopenia. - At slide 35 doctor mean by risk factors which are the smoking, radiation, chemicals etc. - At slide 36 recall that - normal number of blast at bone marrow is 5%. - Classification of MDS according to number of blast fall into three categories (0-6%,6-10%,11-19%) - If blast more than 20% this disease called acute myloid leukemia (AML). - Sidieroblstic ring is accumulation of iron at mitochondria which usually found around nucleus, it needs special stain to see it under microscope. - Hyposegmented nuclei mean just one or two segment. Also, hypolobulated nuclei at megakaryocyte it's one or two lobule. - Slide 37 the note here is that it's called refractory ; because it's untreated, another thing is RAEB-2 has more probability to progress to acute myloid leukemia(aml). - Slide 38 : most common case of refractory cytopenia with unilinage dusplasia is erythroid linage (refractory anemia with ring sideroblast ) and its best prognosis also, its rarely progress to AML. Take attention of slide 39.

Acute myloid leukemia - High number of mutations lead level. to AML at both levels chromosomal and gne - Remember that myeoprolifrative disease(mpd) occur at gene level and myelodisplastic syndrome(mds) occur at cheomosomal level. - (AML affect all ages) while (MPD affects elderly) and (MDS affects middle aged.) - AML pathogenesis affects both differentiation and proliferation level so cells aren t mature but still proliferate. - Slide 41 FAB (French American British) classification morphology. depends on - M1: AML without maturation i.e. blast has the biggest percentage 80% or more. - M2: AML with maturation but little mature cell with blast (immature cell) the highest percentage of bone marrow cells. - M3: acute promyelocytic leukemia (here myeloblast has one step maturation to promyelocyte and arrest there), patients with M3 develop DIC commonly bleed and die of bleeding. - M4:acute myelomonocytic leukemia, occur when high proliferation of monocyte and neutrophils (don't forget even the monocyte and neutrophil number increase here but the percentage of blast should still above of 20% to call AML) - To more understanding, if I have 20%balst cell and the type is M4 then the rest cells are monocyte and neutrophils. - M5: acute monocytic leukemia, more than 20%blast. when high proliferation of monocyte with - M6: acute erthrocytic leukemia, increase number of erythrocytic vell (nucleated RBC) with more than 20% blast

- M7: acute megakaryocytic leukemia, increase number of megakaryocyte with more than 20% blast. Notice that M6 and M7 are rare cases. Slide 42 - WHO depend morphology and other criteria like mutations etc. - While FAB depend on morphology and it's older but still used. - WHO most important clinically. - Inversion 11 is poor prognosis while t(8;21) is good prognosis. - At 4 th point (AML not otherwise specified ) here going back to FAB classification. Slide 46 - PML (promyelocytic leukemia) gene found at chromosome 15 while RARA (retonic acid receptor alpha) - DIC which cause hemolytic anemia(microangiopathic hemolytic anemia) producing schstocyte, cellbleeding because of releasing of anti- coagulation factor to remove thrombus, thrompocytopenia. - So schstocyte, low platelet, increase promylocyte mean M3 (acute promyelocytic leukemia) Slide 47 - Promyelocte differ from myeloblast. Promyelocyte larger, more greanulated and auer rods commonly found - Auer rods is accumulation of granules contain enzyme found at cytoplasm of the blast cell at AML. Done by : ali abualhija. "عليك بذكر هللا تعالى فانه دواء واياك وذكر الناس فانه داء" عمر بن الخطاب